On December 17, 2025, the U.S. Food and Drug Administration (FDA) approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) for subcutaneous injection, commonly known as a shot. This approval included all the same uses of Rybrevant (amivantamab) that the FDA previously approved for adults with metastatic non-small cell lung cancer (NSCLC) whose tumors have an [...]
Did you know? HER2 is a gene found in cells that is important for cell growth and survival. You may also sometimes see HER2 referred to by the name ERBB-2. In some people, the HER2 gene begins to change [...]
One of the newer developments in the cancer testing and diagnostic space is the rise of minimal residual disease (MRD) testing. However, there can be confusion surrounding what it is, how it works, and whether it's a good fit [...]
By Andrew Ciupek and Brittney Nichols The GO2 team attended the 2025 World Conference on Lung Cancer, where researchers from around the world shared the latest findings and breakthroughs in lung cancer research. Here are some of the key updates [...]
On October 2, 2025, the U.S. Food and Drug Administration (FDA) approved Zepzelca (lurbinectedin) in combination with Tecentriq (atezolizumab) or Tecentriq Hybreza (atezolizumab and hyaluronidase-tqjs) as maintenance therapy for adult patients with extensive-stage small cell lung cancer (ES-SCLC) whose disease [...]
When it comes to lung cancer, medical guidelines change as doctors learn more. It’s important to stay on top of these changes because they can directly impact your care. Recently, the National Comprehensive Cancer Network (NCCN) updated its guidelines for [...]
On September 19, 2025, the U.S. Food and Drug Administration (FDA) approved a new administration method for Keytruda (pembrolizumab). Under the new approval, Keytruda Qlex (pembrolizumab and berahyaluronidase alfa-pmph) can now be given by subcutaneous injection, commonly known as a shot, [...]
The World Conference on Lung Cancer (WCLC) is the largest and most influential global gathering focused entirely on lung cancer. This year, the conference will be held in Barcelona, Spain, where researchers, clinicians, and advocates from around the world [...]
Did you know? HER2 is a gene found in cells that is important for cell growth and survival. You may also sometimes see HER2 referred to by the name ERBB-2. In some people, the HER2 gene begins to mutate [...]
By Matthew Reiss, MSE, PhD, Manager, Precision Medicine & Navigation, GO2 for Lung Cancer This is the second blog post of our ongoing “Understanding Lung Cancer” series, which aims to simplify the science behind lung cancer and help provide [...]